Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults

Targeting kinases linked to insulin resistance (IR) and inflammation may help in reducing the risk of type 2 diabetes (T2D) and Alzheimer’s disease (AD) in its early stages. This study aimed to determine whether DHA-rich fish oil supplementation reduces glycogen synthase kinase (GSK-3), which is lin...

Full description

Bibliographic Details
Main Authors: Rohith N. Thota, Jessica I. Rosato, Tracy L. Burrows, Cintia B. Dias, Kylie A. Abbott, Ralph N. Martins, Manohar L. Garg
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/6/1612
_version_ 1797566579374817280
author Rohith N. Thota
Jessica I. Rosato
Tracy L. Burrows
Cintia B. Dias
Kylie A. Abbott
Ralph N. Martins
Manohar L. Garg
author_facet Rohith N. Thota
Jessica I. Rosato
Tracy L. Burrows
Cintia B. Dias
Kylie A. Abbott
Ralph N. Martins
Manohar L. Garg
author_sort Rohith N. Thota
collection DOAJ
description Targeting kinases linked to insulin resistance (IR) and inflammation may help in reducing the risk of type 2 diabetes (T2D) and Alzheimer’s disease (AD) in its early stages. This study aimed to determine whether DHA-rich fish oil supplementation reduces glycogen synthase kinase (GSK-3), which is linked to both IR and AD. Baseline and post-intervention plasma samples from 58 adults with abdominal obesity (Age: 51.7 ± 1.7 years, BMI: 31.9 ± 0.8 kg/m<sup>2</sup>) were analysed for outcome measures. Participants were allocated to 2 g DHA-rich fish oil capsules (860 mg DHA + 120 mg EPA) (n = 31) or placebo capsules (n = 27) per day for 12 weeks. Compared to placebo, DHA-rich fish oil significantly reduced GSK-3β by −2.3 ± 0.3 ng/mL. An inverse correlation (<i>p</i> < 0.05) was found between baseline insulin and IR and their changes following intervention only in participants with C-reactive protein levels higher than 2.4 mg/L. DHA-rich fish oil reduces GSK-3 and IR, suggesting a potential role of long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) in ameliorating AD risk.
first_indexed 2024-03-10T19:28:53Z
format Article
id doaj.art-9e5c182f8f3a4b56bdc6ea85f96c6ee7
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T19:28:53Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-9e5c182f8f3a4b56bdc6ea85f96c6ee72023-11-20T02:18:41ZengMDPI AGNutrients2072-66432020-05-01126161210.3390/nu12061612Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife AdultsRohith N. Thota0Jessica I. Rosato1Tracy L. Burrows2Cintia B. Dias3Kylie A. Abbott4Ralph N. Martins5Manohar L. Garg6Nutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, AustraliaNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, AustraliaSchool of Health Sciences, University of Newcastle, Callaghan NSW 2308, AustraliaNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, AustraliaNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, AustraliaDepartment of Biomedical Sciences, Macquarie University, North Ryde NSW 2109, AustraliaNutraceuticals Research Program, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan NSW 2308, AustraliaTargeting kinases linked to insulin resistance (IR) and inflammation may help in reducing the risk of type 2 diabetes (T2D) and Alzheimer’s disease (AD) in its early stages. This study aimed to determine whether DHA-rich fish oil supplementation reduces glycogen synthase kinase (GSK-3), which is linked to both IR and AD. Baseline and post-intervention plasma samples from 58 adults with abdominal obesity (Age: 51.7 ± 1.7 years, BMI: 31.9 ± 0.8 kg/m<sup>2</sup>) were analysed for outcome measures. Participants were allocated to 2 g DHA-rich fish oil capsules (860 mg DHA + 120 mg EPA) (n = 31) or placebo capsules (n = 27) per day for 12 weeks. Compared to placebo, DHA-rich fish oil significantly reduced GSK-3β by −2.3 ± 0.3 ng/mL. An inverse correlation (<i>p</i> < 0.05) was found between baseline insulin and IR and their changes following intervention only in participants with C-reactive protein levels higher than 2.4 mg/L. DHA-rich fish oil reduces GSK-3 and IR, suggesting a potential role of long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) in ameliorating AD risk.https://www.mdpi.com/2072-6643/12/6/1612long-chain omega-3 polyunsaturated fatty acidsdocosahexaenoic acidinsulin resistanceobesityAlzheimer’s diseaseglycogen synthase kinase-3
spellingShingle Rohith N. Thota
Jessica I. Rosato
Tracy L. Burrows
Cintia B. Dias
Kylie A. Abbott
Ralph N. Martins
Manohar L. Garg
Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
Nutrients
long-chain omega-3 polyunsaturated fatty acids
docosahexaenoic acid
insulin resistance
obesity
Alzheimer’s disease
glycogen synthase kinase-3
title Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
title_full Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
title_fullStr Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
title_full_unstemmed Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
title_short Docosahexaenoic Acid-Rich Fish Oil Supplementation Reduces Kinase Associated with Insulin Resistance in Overweight and Obese Midlife Adults
title_sort docosahexaenoic acid rich fish oil supplementation reduces kinase associated with insulin resistance in overweight and obese midlife adults
topic long-chain omega-3 polyunsaturated fatty acids
docosahexaenoic acid
insulin resistance
obesity
Alzheimer’s disease
glycogen synthase kinase-3
url https://www.mdpi.com/2072-6643/12/6/1612
work_keys_str_mv AT rohithnthota docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT jessicairosato docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT tracylburrows docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT cintiabdias docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT kylieaabbott docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT ralphnmartins docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults
AT manoharlgarg docosahexaenoicacidrichfishoilsupplementationreduceskinaseassociatedwithinsulinresistanceinoverweightandobesemidlifeadults